Wall Street Analysts Think Rigel (RIGL) Could Surge 82.3%: Read This Before Placing a Bet

Group 1 - Rigel Pharmaceuticals (RIGL) shares have increased by 7% over the past four weeks, closing at $18.47, with a mean price target of $33.67 indicating a potential upside of 82.3% [1] - The average price targets from analysts range from a low of $20 to a high of $57, with a standard deviation of $17.36, suggesting variability in estimates [2] - Analysts have shown strong agreement in revising earnings estimates higher, which correlates with potential stock price increases [4][11] Group 2 - The Zacks Consensus Estimate for RIGL's current year earnings has risen by 1.5% over the past month, with no negative revisions [12] - RIGL holds a Zacks Rank 1 (Strong Buy), placing it in the top 5% of over 4,000 ranked stocks based on earnings estimates [13] - While the consensus price target may not be a reliable indicator of the stock's potential gain, it does suggest a positive direction for price movement [13]